» Articles » PMID: 35263054

Antenatal Corticosteroids May Contribute to Illness in Children in the Future

Overview
Specialty Endocrinology
Date 2022 Mar 9
PMID 35263054
Authors
Affiliations
Soon will be listed here.
References
1.
Maggi R, Dondi D, Piccolella M, Casulari L, Martini L . New insight on the molecular aspects of glucocorticoid effects in nervous system development. J Endocrinol Invest. 2013; 36(9):775-80. DOI: 10.3275/9003. View

2.
Astiz M, Heyde I, Fortmann M, Bossung V, Roll C, Stein A . The circadian phase of antenatal glucocorticoid treatment affects the risk of behavioral disorders. Nat Commun. 2020; 11(1):3593. PMC: 7367845. DOI: 10.1038/s41467-020-17429-5. View

3.
Alexander N, Rosenlocher F, Dettenborn L, Stalder T, Linke J, Distler W . Impact of Antenatal Glucocorticoid Therapy and Risk of Preterm Delivery on Intelligence in Term-Born Children. J Clin Endocrinol Metab. 2015; 101(2):581-9. DOI: 10.1210/jc.2015-2453. View

4.
McKinlay C, Dalziel S, Harding J . Antenatal glucocorticoids: where are we after forty years?. J Dev Orig Health Dis. 2014; 6(2):127-42. DOI: 10.1017/S2040174414000579. View

5.
Oladapo O, Vogel J, Piaggio G, Nguyen M, Althabe F, Gulmezoglu A . Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries. N Engl J Med. 2020; 383(26):2514-2525. PMC: 7660991. DOI: 10.1056/NEJMoa2022398. View